DALLAS-FORT WORTH, TX — May 3, 2024— BioStone Animal Health is pleased to announce the launch of the AsurDxTM FMDV Type SAT2 Antibody cELISA Test Kit (Bovine/Ovine/Caprine/Swine) designed for the detection of antibodies specific to multispecies of foot and mouth disease virus (FMDV) serotype SAT2 in bovine, ovine, caprine or swine origin. Foot and mouth disease (FMD) is caused by the FMD virus (FMDV), which is a member of the genus Aphthovirus and the family Picornaviridae. FMD is one of the most highly contagious and economically devastating diseases of cloven-hoofed animals, and it severely constrains the international trade of animals and animal products.
The AsurDxTM FMDV Type SAT2 Antibody cELISA Test Kit detects FMDV serotype SAT2 antibodies in serum and plasma samples from infected or vaccinated bovine, ovine, caprine or swine origin. The AsurDxTM FMDV Type SAT2 Antibody cELISA Test Kit provides a simple, rapid, sensitive and specific competitive enzyme-based immunoassay (cELISA) screening method.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. By making these test kits available to the international community, BioStone strives to actively promote and participate in global animal health initiatives. For more information about BioStone Animal Health, visit www.biostoneah.com
